New hope for Hard-to-Treat GIST: experimental drug DCC-3009 enters human trials
Disease control
Recruiting now
This study tests a new drug called DCC-3009, alone or with other cancer medicines, for people with advanced gastrointestinal stromal tumor (GIST) that has stopped responding to standard treatments. The goal is to find safe doses and see if the drug can shrink tumors. About 120 ad…
Phase: PHASE1, PHASE2 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC